Skip to content
DraconiticResearch
Search Sources API
203,234 studies31 sourcesUpdated 29 min ago
Peer-reviewedCC BY-NCIranian journal of biotechnology

Design and In Silico Evaluation of a Cry1Ac/XptC Hybrid Protein Targeting the APN Receptor in Manduca sexta.

4 affiliations
  1. 1Department of Plant Breeding and Biotechnology, University of Zabol, Zabol, Iran.
  2. 2Industrial Biotechnology Group, Biotechnology Research Center, Ferdowsi University of Mashhad, Mashhad, Iran.
  3. 3Laboratory of Computational Biotechnology and Bioinformatics (CBB), Department of Bioinformatics, Faculty of Basic Sciences, University of Zabol, Zabol, Iran.
  4. 4Department of Biology, Ferdowsi University of Mashhad, Mashhad, Iran.

Abstract

Background

The widespread use of Bacillus thuringiensis (Bt) Cry toxins has led to the evolution of resistance in target insect pests, posing a significant threat to sustainable agriculture. Manduca sexta, a major pest of Solanaceae crops, is developing resistance to conventional Cry1Ac toxins, necessitating the development of novel, high-efficacy molecular alternatives.Objectives

This study aimed to design and computationally evaluate a novel hybrid toxin, RCGX1, by fusing functional domains of Cry1Ac and XptC proteins. The novelty of this approach lies in the rational fusion of domains from distinct bacterial toxin classes (Bacillus and Xenorhabdus) to create an emergent, neo-binding site, a strategy that moves beyond conventional single-toxin modifications.Materials and methods

Functional domains were identified using InterPro: the galactose-binding domain of Cry1Ac (residues 462-609) and the SpvB toxin domain of XptC (residues 32-278). These domains were fused via a flexible (SSGG)4 linker to create the hybrid protein RCGX1. The 3D structure was predicted using I-TASSER and refined through energy minimization(converging in 730 steps). The quality of the model was validated using VERIFY3D, PROCHECK, and ERRAT. Molecular dynamics (MD) simulations (200 ns) were performed using GROMACS (CHARRM 27 force field) to assess structural stability. with analyses of Root Mean Square Deviation (RMSD), Root Mean Square Fluctuation (RMSF), Radius of Gyration (Rg), and hydrogen bond formation. Molecular docking by APN receptor was done using ClusPro to evaluate binding affinity and interaction sites.Results

MD simulations demonstrated robust structural stability, with RMSD stabilizing at ~0.65 nm and Rg averaging 2.4 nm, indicating a compact and stable conformation. Docking revealed a high-affinity interaction (-1437.0 kcal.mol-1) unexpectedly mediated by the XptC moiety. The interface is anchored by a multivalent Arg36-Glu195 salt bridge, which is structurally reinforced by a local hydrophobic cage (Trp31/Phe34) and a specific hydrogen-bond network orchestrated by Gln125 and Gly284, creating a robust, engineered epitope distinct from canonical Cry toxins.Conclusion

The designed hybrid protein RCGX1 exhibits exceptional structural stability and a potent, specific binding affinity in silico. These results strongly suggest that RCGX1 is a compelling candidate for a new class of dual-function toxins. RCGX1 is thus positioned as a powerful lead candidate for experimental validation, offering a promising strategy capable of countering established Bt resistance pathways and paving the way for the development of next-generation biopesticides.

Related

  1. Immunoinformatics design and in vitro evaluation of dendritic cell-targeting brucellosis multi-epitope vaccine based on Omp28 and GroEL
    Xuanji Zhang, Na Chen, Juan Shi +7
    Scientific ReportsPeer-reviewedCC BY-NC-ND 4.0Full textMolecular biology & gene regulationCrossref
  2. Structure-guided design and dynamic evaluation of VP4-targeting siRNAs against rotavirus A
    Abu Nayeem Ahmed, Khaleda Jahan Satu, A. B. Z. Naimur Rahman +8
    Scientific ReportsPeer-reviewedCC BY-NC-ND 4.0Full textMolecular biology & gene regulationCrossref
  3. Computationally Guided Design and Experimental Validation of ssDNA Aptamers Targeting the SARS-CoV-2 Spike Protein
    José C. E. Márquez Montesinos, Ana Maria Bernardez, Yuliet Mazola +11
    BiomoleculesPeer-reviewedCC BY 4.0Full textMolecular biology & gene regulationCrossrefEurope PMCDOAJ
  4. CP-GFM-SGX: Topology-Aware Cyclic Peptide Generation and Design with Receptor-Conditioned Structural Evaluation and Experimental KRAS Affinity Optimization
    Zhiyuan Hu, Russell Dillworth
    ChemRxivPreprintCC BYFull textMolecular biology & gene regulationChemRxiv
  5. Spatial encryption of G protein-coupled receptor signaling in endosomes; Mechanisms and applications
    Silvia Sposini, Aylin Hanyaloglu
    Biochemical PharmacologyPeer-reviewedCC BY-NC-ND26 citedMolecular biology & gene regulationHAL
BibTeX
@article{rashidabadi2026design,
  title = {{Design and In Silico Evaluation of a Cry1Ac/XptC Hybrid Protein Targeting the APN Receptor in Manduca sexta.}},
  author = {Mohammad Javad Rashidabadi and Mahmood Solouki and Aliakbar Haddad-Mashadrizeh and Abbasali Emamjomeh and Ali Makhdoumi},
  journal = {Iranian journal of biotechnology},
  year = {2026},
  month = oct,
  doi = {10.30498/ijb.2026.554854.4284},
  url = {https://europepmc.org/article/MED/42928841},
  note = {CC BY-NC},
}
RIS
TY  - JOUR
TI  - Design and In Silico Evaluation of a Cry1Ac/XptC Hybrid Protein Targeting the APN Receptor in Manduca sexta.
AU  - Mohammad Javad Rashidabadi
AU  - Mahmood Solouki
AU  - Aliakbar Haddad-Mashadrizeh
AU  - Abbasali Emamjomeh
AU  - Ali Makhdoumi
PY  - 2026
DA  - 2026/10/01
JO  - Iranian journal of biotechnology
DO  - 10.30498/ijb.2026.554854.4284
UR  - https://europepmc.org/article/MED/42928841
AB  - Background  The widespread use of Bacillus thuringiensis (Bt) Cry toxins has led to the evolution of resistance in target insect pests, posing a significant threat to sustainable agriculture. Manduca sexta, a major pest of Solanaceae crops, is developing resistance to conventional Cry1Ac toxins, necessitating the development of novel, high-efficacy molecular alternatives.Objectives  This study aimed to design and computationally evaluate a novel hybrid toxin, RCGX1, by fusing functional domains of Cry1Ac and XptC proteins. The novelty of this approach lies in the rational fusion of domains from distinct bacterial toxin classes (Bacillus and Xenorhabdus) to create an emergent, neo-binding site, a strategy that moves beyond conventional single-toxin modifications.Materials and methods  Functional domains were identified using InterPro: the galactose-binding domain of Cry1Ac (residues 462-609) and the SpvB toxin domain of XptC (residues 32-278). These domains were fused via a flexible (SSGG)4 linker to create the hybrid protein RCGX1. The 3D structure was predicted using I-TASSER and refined through energy minimization(converging in 730 steps). The quality of the model was validated using VERIFY3D, PROCHECK, and ERRAT. Molecular dynamics (MD) simulations (200 ns) were performed using GROMACS (CHARRM 27 force field) to assess structural stability. with analyses of Root Mean Square Deviation (RMSD), Root Mean Square Fluctuation (RMSF), Radius of Gyration (Rg), and hydrogen bond formation. Molecular docking by APN receptor was done using ClusPro to evaluate binding affinity and interaction sites.Results  MD simulations demonstrated robust structural stability, with RMSD stabilizing at ~0.65 nm and Rg averaging 2.4 nm, indicating a compact and stable conformation. Docking revealed a high-affinity interaction (-1437.0 kcal.mol-1) unexpectedly mediated by the XptC moiety. The interface is anchored by a multivalent Arg36-Glu195 salt bridge, which is structurally reinforced by a local hydrophobic cage (Trp31/Phe34) and a specific hydrogen-bond network orchestrated by Gln125 and Gly284, creating a robust, engineered epitope distinct from canonical Cry toxins.Conclusion  The designed hybrid protein RCGX1 exhibits exceptional structural stability and a potent, specific binding affinity in silico. These results strongly suggest that RCGX1 is a compelling candidate for a new class of dual-function toxins. RCGX1 is thus positioned as a powerful lead candidate for experimental validation, offering a promising strategy capable of countering established Bt resistance pathways and paving the way for the development of next-generation biopesticides.
SN  - 1728-3043
SN  - 2322-2921
ER  -